{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8L925",
      "entity_text" : "CRC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P54753",
      "entity_text" : "EPHB3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "EPHB3 also interacts with integrin beta1 to increase both tumor invasion and progress, raising the possibility that targeting EPHB3 may modulate integrin beta1 signaling in CRC.",
  "reading_complete" : "2020-08-03T09:12:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:11:36Z",
  "trigger" : "raising",
  "evidence" : [ "EPHB3 also interacts with integrin beta1 to increase both tumor invasion and progress, raising the possibility that targeting EPHB3 may modulate integrin beta1 signaling in CRC" ],
  "pmc_id" : "6531304",
  "score" : 0
}